EN 
FR INVESTING IN THE FUTURE OF
Linearis with its tandem Ventures Fund and Laboratory is pioneering and supporting discoveries to prevent, detect, and cure metabolic diseases including cancers & diabetes through direct investments in innovative AI-powered life sciences companies.
Metabolomics
Genomics
DISEASES
SIGNATURES
PREVENTION
DIAGNOSTIC
monitoring
drug discovery
ABOUT LINEARIS
Linearis is transforming healthcare by merging artificial intelligence and biomarker analysis to enhance patient care with more precise, accessible prevention, detection, treatment of metabolic diseases including cancer, diabetes, and antimicrobial resistance.
